News
Contact Us
Support

Home
Our Philosophy
OVITEX
Investors
Careers

Press Releases
Events & Presentations

News Releases

News Releases

Year

Mar 29, 2023

TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023

Mar 23, 2023

TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

Mar 21, 2023

TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 16, 2023

TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications

Feb 28, 2023

TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results

Feb 24, 2023

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 21, 2023

TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques

Feb 14, 2023

TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization

Jan 20, 2023

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 09, 2023

TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds

Print Page

RSS Feeds

Email Alerts

Contact IR

Privacy Policy
Legal
Contact Us

Linkedin
Facebook
Twitter
Instagram

©2023 TELA Bio, Inc. All Rights reserved.